Phone : +91-22-2207 0099 Email : info@ottokemi.com, sales@ottokemi.com
(((S)-1-carboxy-5-((S)-3-(naphthalen-2-yl)-2- ((1r,4S)-4-((2-(4,7,10-tris(carboxymethyl)- 1,4,7,10-tetraazacyclododecan-1- yl)acetamido)methyl)cyclohexane-1- carboxamido)propanamido)pentyl)carbamoyl)- L-glutamic acid tetra(trifluoroacetic acid)
PS 0495
C57H75F12N9O24· xTFA
29420090
18%
1498.25
Vial / Bottle
PS 0495 (OTTO) PSMA-617.TFA Cas 1702967-37-0 - used in chemical research.
PSMA-617 - a novel theranostic PSMA inhibitor for both diagnosis and endoradiotherapy of prostate cancer.
Cell biology, Cancer research
98%+
Powder
Colourless to white to off-white
1041.5019
-20 °C
Safety Information for this product is unavailable at this time.
DisclaimerThe above particulars do not release the customer from the obligation to carry out an inspection of goods received. For laboratory use only. Not for drug, medical, household, or any other unauthorized application. We assume no liability for misuse or unauthorized application of the product. Please test before use.